Dr. Muhammad Ahmad Mujtaba , MD
Internal Medicine - Nephrology • Webster, TX
600 N Kobayashi Ste 112
Webster, TX 775984841
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Muhammad Mujtaba is listed in NPPES under Internal Medicine - Nephrology.
-
NPI assigned on December 29, 2008; this date does not establish years in practice.
-
Published CMS data list 494 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99214 — Established patient outpatient office visit: 178 service units.
- 99233 — Subsequent hospital care with moderate levelof medical decision making: 82 service units.
- G2211 — Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's: 71 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 8 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 2,471 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Prednisone — 359 prescription fills, including refills.
- Carvedilol — 247 prescription fills, including refills.
- Pantoprazole Sodium — 179 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 42 records in the table · Guide: How to read Medicare Part D prescriber data
-
Fewer Medicare Part B services than 70% of clinicians listed under Internal Medicine - Nephrology in Webster, TX (2024, 12 clinicians with data). Median for this group: 1,355. Middle half: 479 to 2,142.
Fewer Medicare Part B services than 75% of clinicians listed under Internal Medicine - Nephrology in Texas (2024, 900 clinicians with data). Median for this group: 1,229. Middle half: 627 to 2,176.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 840 in 2020 to 494 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
600 N Kobayashi Ste 112
Webster, TX 775984841
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
NPPES lists 3 distinct additional practice-address records in Baytown, TX; Houston, TX. See the list
Source: CMS NPPES NPI Registry, practice location records; release date unavailable.
CMS Doctors and Clinicians lists 1 group name: Jajja Health Pllc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
1999
What Public CMS Data Show
Internal Medicine - Nephrology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
226 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $45,004 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $33,472 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
3,802 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$639,536 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $295.59 across 15 records.
By nature of payment
- Food and Beverage: $295.59 across 15 records.
Reporting-company totals (3 largest of 10)
- Amgen Inc.: $104.27 across 6 records.
- Veloxis Pharmaceuticals, Inc.: $35.75 across 1 record.
- Apellis Pharmaceuticals, Inc.: $28.26 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
27 years (graduated 1999)
CMS Doctors and Clinicians data list 1999 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2008
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Mujtaba has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Mujtaba as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Webster and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Fewer Medicare Part B services than 70% of clinicians listed under Internal Medicine - Nephrology in Webster, TX (2024, 12 clinicians with data). Median for this group: 1,355. Middle half: 479 to 2,142.
Fewer Medicare Part B services than 75% of clinicians listed under Internal Medicine - Nephrology in Texas (2024, 900 clinicians with data). Median for this group: 1,229. Middle half: 627 to 2,176.
Medicare-allowed amount
A lower Medicare-allowed amount than 95% of clinicians listed under Internal Medicine - Nephrology in Webster, TX (2024, 12 clinicians with data). Median for this group: $138,462. Middle half: $78,414 to $265,727.
A lower Medicare-allowed amount than 85% of clinicians listed under Internal Medicine - Nephrology in Texas (2024, 900 clinicians with data). Median for this group: $146,330. Middle half: $81,178 to $228,491.
Paid by Medicare
A lower Medicare payment amount than 95% of clinicians listed under Internal Medicine - Nephrology in Webster, TX (2024, 12 clinicians with data). Median for this group: $109,597. Middle half: $61,968 to $210,627.
A lower Medicare payment amount than 85% of clinicians listed under Internal Medicine - Nephrology in Texas (2024, 900 clinicians with data). Median for this group: $112,021. Middle half: $63,642 to $175,741.
Medicare Part D prescriptions
More Part D prescriptions than 90% of clinicians listed under Internal Medicine - Nephrology in Webster, TX (2024, 12 clinicians with data). Median for this group: 1,279. Middle half: 468 to 1,877.
More Part D prescriptions than 85% of clinicians listed under Internal Medicine - Nephrology in Texas (2024, 890 clinicians with data). Median for this group: 976. Middle half: 396 to 1,679.
Part D drug cost
A higher Part D drug cost than 90% of clinicians listed under Internal Medicine - Nephrology in Webster, TX (2024, 12 clinicians with data). Median for this group: $151,406. Middle half: $42,982 to $347,090.
A higher Part D drug cost than 85% of clinicians listed under Internal Medicine - Nephrology in Texas (2024, 890 clinicians with data). Median for this group: $157,200. Middle half: $45,012 to $339,428.
13 active clinicians are listed under Internal Medicine - Nephrology with a practice address in Webster, TX (1,161 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Webster
46.2% of these 13 clinicians have the CMS telehealth indicator.
100% of these 13 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 41% from 840 in 2020 to 494 in 2024.
- 2020: 840
- 2021: 761
- 2022: 533
- 2023: 540
- 2024: 494
-
Medicare-allowed amount
Medicare-allowed amount decreased 40% from $75,281 in 2020 to $45,004 in 2024.
- 2020: $75,281
- 2021: $77,132
- 2022: $50,405
- 2023: $52,618
- 2024: $45,004
-
Paid by Medicare
Paid by Medicare decreased 43% from $58,731 in 2020 to $33,472 in 2024.
- 2020: $58,731
- 2021: $60,494
- 2022: $38,386
- 2023: $41,272
- 2024: $33,472
-
Medicare Part D prescriptions
Medicare Part D prescriptions varied from year to year: 2,515 in 2020 and 2,471 in 2024.
- 2020: 2,515
- 2021: 1,917
- 2022: 1,714
- 2023: 1,808
- 2024: 2,471
-
30-day fills
30-day fills varied from year to year: 3,671 in 2020 and 3,802 in 2024.
- 2020: 3,671
- 2021: 3,042
- 2022: 2,582
- 2023: 2,596
- 2024: 3,802
-
Part D drug cost
Part D drug cost increased 12% from $569,740 in 2020 to $639,536 in 2024.
- 2020: $569,740
- 2021: $386,825
- 2022: $452,439
- 2023: $358,344
- 2024: $639,536
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $117.72 in 2021 to $295.59 in 2025.
- 2021: $117.72
- 2022: $14,466.32
- 2023: $55,606.42
- 2024: $100.92
- 2025: $295.59
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 15 records totaling $295.59.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Veloxis Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
ENVARSUS | General | $35.75 |
| Apellis Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
Empaveli | General | $28.26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC |
Food and Beverage
In-kind items and services
|
XIFAXAN | General | $24.27 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
KRYSTEXXA | General | $22.54 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
TAVNEOS | General | $21.38 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $20.77 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $18.76 |
| AKEBIA THERAPEUTICS INC |
Food and Beverage
In-kind items and services
|
Vafseo | General | $16.98 |
| Exact Sciences Corporation |
Food and Beverage
In-kind items and services
|
Cologuard Collection Kit | General | $16.23 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
TAVNEOS | General | $16.22 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Rybelsus | General | $15.58 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
TAVNEOS | General | $15.16 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
KRYSTEXXA | General | $15.11 |
| ANI Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
PURIFIED CORTROPHIN GEL | General | $14.72 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
KRYSTEXXA | General | $13.86 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
178 | 124 | $277.21 | $94.62 |
|
99233
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
|
82 | 34 | $297.39 | $114.90 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
71 | 63 | $43.87 | $16.01 |
|
99232
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
|
63 | 31 | $197.70 | $76.33 |
|
99223
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
|
32 | 31 | $436.57 | $170.51 |
|
90935
Hemodialysis procedure with physician evaluation
|
26 | 21 | $177.40 | $68.56 |
|
99222
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
|
24 | 24 | $338.75 | $126.28 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
18 | 18 | $363.61 | $140.26 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Prednisone | Prednisone | 359 | 14,960 | $1,578.08 | 84 |
| Carvedilol | Carvedilol | 247 | 12,649 | $1,443.89 | 63 |
| Pantoprazole Sodium | Pantoprazole Sodium | 179 | 8,411 | $1,008.42 | 38 |
| Furosemide | Furosemide | 151 | 7,275 | $623.50 | 48 |
| Famotidine | Famotidine | 131 | 5,880 | $934.48 | 30 |
| Amlodipine Besylate | Amlodipine Besylate | 109 | 7,110 | $543.49 | 41 |
| Cinacalcet Hcl | Cinacalcet Hcl | 102 | 4,140 | $29,952.99 | 24 |
| Farxiga | Dapagliflozin Propanediol | 86 | 2,880 | $49,586.83 | 20 |
| Nifedipine Er | Nifedipine | 80 | 3,980 | $2,313.29 | 18 |
| Metoprolol Tartrate | Metoprolol Tartrate | 72 | 3,780 | $274.22 | 21 |
| Nulojix | Belatacept | 72 | 1,989 | $187,405.18 | — |
| Lisinopril | Lisinopril | 68 | 4,652 | $412.40 | 23 |
| Tamsulosin Hcl | Tamsulosin Hcl | 68 | 3,240 | $584.25 | 20 |
| Clonidine Hcl | Clonidine Hcl | 63 | 2,380 | $290.78 | 14 |
| Losartan Potassium | Losartan Potassium | 59 | 3,780 | $310.38 | 27 |
| Valganciclovir Hcl | Valganciclovir Hcl | 56 | 1,905 | $8,802.44 | 22 |
| Hydralazine Hcl | Hydralazine Hcl | 41 | 2,083 | $517.83 | 14 |
| Gabapentin | Gabapentin | 35 | 1,470 | $209.79 | — |
| Mycophenolic Acid | Mycophenolate Sodium | 33 | 1,140 | $2,503.93 | 12 |
| Atorvastatin Calcium | Atorvastatin Calcium | 32 | 1,800 | $229.21 | — |
| Metoprolol Succinate | Metoprolol Succinate | 31 | 1,590 | $422.19 | — |
| Calcitriol | Calcitriol | 31 | 1,350 | $485.42 | — |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 30 | 1,097 | $260.78 | 11 |
| Leflunomide | Leflunomide | 27 | 1,743 | $1,591.31 | — |
| Spironolactone | Spironolactone | 24 | 1,110 | $156.09 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2026-06-01NUCC Taxonomy Code: 207RN0300X
An internist who treats disorders of the kidney, high blood pressure, fluid and mineral balance and dialysis of body wastes when the kidneys do not function. This specialist consults with surgeons about kidney transplantation.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - NEPHROLOGY
I20241203000670
WV
7214077718
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Jajja Health Pllc
1602 W Baker Rd, Baytown, TX 775212282
Phone: 2814284024
Secondary Practice Locations
1642 W Baker Rd Ste C
Baytown, TX 775212406
Phone: 3466426891
6051 Garth Rd Ste 1100
Baytown, TX 775219892
Phone: 3466426891
11914 Astoria Blvd Ste 480
Houston, TX 770896085
Phone: 3466426891
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Family Medicine
Doctor of Medicine (M.D.)
Nurse Practitioner - Family
Family Nurse Practitioner (Certified)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 600 N KOBAYASHI STE 112, WEBSTER, TX 775984841 (Tel: 3466426891)
Registered at 600 N KOBAYASHI STE 112, WEBSTER, TX 775984841 (Tel: 3466426891)
Internal Medicine (license number reported to NPPES: TX R0622)
Registered at 250 N SHADELAND AVE STE 200, INDIANAPOLIS, IN 462194959 (Tel: 3172744402)
Registered at 250 N SHADELAND AVE, STE 200, INDIANAPOLIS, IN 462194959 (Tel: 3172744402)
NPI status registered as active in NPPES database
Registered at 550 UNIVERSITY BLVD, UH2180, INDIANAPOLIS, IN 462025149 (Tel: 3172744370)
Registered at PO BOX 44994, INDIANAPOLIS, IN 462440994 (Tel: 3172744402)
Recorded as MUHAMMAD MUJTABA, M.D.
Internal Medicine (license number reported to NPPES: IN 01066894A)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Internal Medicine - Nephrology Specialists in Webster
- Dr. Aziza Sarker, MD
- Dr. Hussein Hussein, MD
- Dr. Katafan Achkar, MD
- Dr. Jingyin Yan, MD, PhD
- Dr. Geetha Seerangan, MD
- Dr. Jayanti Venkatesan, MD
Mailing Address
600 N Kobayashi Ste 112
Webster, TX 775984841
Phone: 3466426891